On April 21, New Journey Health Technology Group Co.,Ltd. (002219) released its first-quarter financial report for 2026. The company reported operating revenue of 720 million yuan, a decrease of 9.6% compared to the same period last year. Net profit attributable to shareholders of the parent company was 20.47 million yuan, down by 20.2% year-on-year. After excluding non-recurring gains and losses, the net profit attributable to shareholders of the parent company stood at 21.99 million yuan, reflecting a decline of 17.1%. Net cash flow from operating activities was negative 12.87 million yuan, but showed an improvement with a 66.1% increase compared to the prior year. The fully diluted earnings per share (EPS) were 0.006 yuan.
As of the end of the first quarter, the company's total assets amounted to 6.568 billion yuan, a slight decrease of 1.2% from the end of the previous fiscal year. The net assets attributable to shareholders of the parent company reached 1.973 billion yuan, marking a 1.0% increase from the end of the prior year.
In terms of business operations, the company primarily focuses on the development and market promotion of health technology products. It is committed to delivering innovative health solutions to meet market demands. By continuously optimizing its product portfolio and enhancing service quality, the company strives to maintain a leading position in a highly competitive market.
Furthermore, the report highlighted the company's shareholder structure and cash flow situation, indicating details regarding its financing activities, debt repayment status, and cash inflows and outflows from investing activities. Overall, the company's operational performance in the first quarter faced certain challenges, yet it managed to sustain business stability.
Comments